Long-term metformin use may lower vitamin B12 levels in people with type 2 diabetes, and this drop could contribute to anemia in some patients. According to Gram Research analysis of a 2026 review, the risk of low B12 rises with higher doses and longer treatment, while the effect on hemoglobin appears small and variable.
Metformin is one of the most common medicines for type 2 diabetes, and many people take it for years. A new 2026 review published in Current Medical Research and Opinion looked at whether long-term use could lead to anemia, a condition where the blood carries too few healthy red cells. According to Gram Research analysis of this review, metformin can lower levels of vitamin B12, a nutrient needed to make red blood cells. The risk of low B12 appears to rise with higher doses and longer use. However, the effect on overall hemoglobin levels and anemia appears small and varies from person to person. Anemia in people with diabetes often has several causes, including kidney disease and iron deficiency, which makes it hard to measure metformin’s exact role. The review suggests that regular blood tests can help catch problems early without stopping a medicine that works well for blood sugar.
Key Statistics
A 2026 narrative review published in Current Medical Research and Opinion found that long-term metformin use can reduce vitamin B12 levels, with the risk of deficiency appearing to increase with higher doses and longer treatment.
According to Gram Research analysis of the same 2026 review, the effect of metformin on hemoglobin and anemia appears modest and varies across patient groups, so it is less clearly established than the link to vitamin B12.
The Quick Take
- What they studied: The researchers asked whether taking metformin for a long time could cause anemia, a shortage of healthy red blood cells, in people with type 2 diabetes. They focused on vitamin B12 because it helps the body make red blood cells.
- Who participated: This was a review of earlier studies rather than a new experiment with patients, so it did not enroll its own group of people. The paper does not report a total number of participants.
- Key finding: The review found that metformin can lower vitamin B12 levels, and the chance of a B12 shortage appears to go up with higher doses and longer use. The effect on hemoglobin, the protein in red blood cells that carries oxygen, was small and inconsistent across studies.
- What it means for you: If you take metformin for a long time, it may be worth asking your doctor whether your vitamin B12 levels should be checked. Do not stop or change your medicine on your own, since metformin also helps control blood sugar.
The Research Details
This study is a narrative review. That means the authors read and summarized many earlier research papers on metformin, vitamin B12, and anemia, then discussed what those papers show together. It is not a single experiment in which people were randomly assigned to take or avoid the medicine.
The authors focused on several questions. They looked at how metformin affects vitamin B12 in the body, whether it changes hemoglobin levels, and how the length of treatment and the dose might matter. They also considered other conditions that can cause anemia in people with diabetes, such as kidney disease and iron deficiency.
The review also discusses how doctors can find problems early. It covers blood tests to check B12 and hemoglobin, and ways to prevent and treat low levels. The goal was to help doctors keep metformin’s blood sugar benefits while watching for avoidable side effects.
Metformin is prescribed to a very large number of people, so even a small effect on blood health could affect many patients. A review that pulls together many studies can show the overall pattern more clearly than any single study can. It also helps separate the strong evidence, such as the link to vitamin B12, from the weaker evidence about hemoglobin.
Narrative reviews are useful for explaining ideas and connecting research, but they are less strict than systematic reviews or meta-analyses. The authors did not describe a formal method for choosing or combining studies, so readers cannot easily check how complete the review is. The conclusions are best read as an expert summary of current thinking, not as a precise measurement of risk.
What the Results Show
The clearest finding in the review is that metformin can reduce the amount of vitamin B12 in the blood. Vitamin B12 is a nutrient the body needs to make healthy red blood cells and to keep nerves working. When levels drop far enough, the result can be a biochemical deficiency, which means the blood test shows low B12 even if symptoms have not yet appeared.
The review reports that this risk appears to grow with higher doses and with longer treatment. In other words, someone who has taken metformin for many years at a high dose may be more likely to have low B12 than someone who started recently at a low dose. The authors describe this as a plausible explanation for how metformin could affect the blood, though this is still an area of active study.
The effect of metformin on hemoglobin, the protein that carries oxygen in red blood cells, is less clear. The review describes this effect as modest and variable, meaning that studies did not agree on how large it is or whether it appears in every group of patients. Hemoglobin levels can also be shaped by many other factors.
Anemia in people with type 2 diabetes often has more than one cause. Kidney disease, iron deficiency, long-term inflammation, blood loss, and other nutrient shortages can all lower hemoglobin. Because these factors often overlap, it is hard to say how much of any anemia is caused by metformin itself.
The review explains that treatment length and total exposure matter. People who have taken metformin for many years may have had more time for B12 levels to drop, which is why long-term monitoring is emphasized. The authors also point to patient and disease factors that may raise risk, though the abstract does not list every one in detail.
The review also stresses that the benefits of metformin for blood sugar are well established. The authors suggest the goal is to reduce preventable blood-related side effects while keeping those benefits, rather than to avoid the medicine altogether.
This review agrees with a growing body of earlier research showing that metformin is linked to lower vitamin B12 levels. The idea that B12 depletion is a likely route to blood problems is widely discussed in medical literature. At the same time, the review confirms that the link between metformin and anemia is less consistent than the link between metformin and B12, which is an important distinction for readers to keep in mind.
The biggest limitation is the study type. A narrative review depends on which studies the authors chose to discuss, and it does not give a single pooled number that shows how common anemia is among metformin users. The paper also does not report a sample size, so it is hard to judge how much evidence sits behind each point.
Anemia is complicated in people with diabetes. Because kidney disease, iron deficiency, and inflammation can all play a role, it is difficult to separate metformin’s effect from these other causes. Readers should also know that the review focuses on mechanisms and clinical considerations, so it does not provide new data on how many patients will be affected in daily life.
The Bottom Line
Confidence is highest that metformin can lower vitamin B12 levels, with the risk appearing to increase with higher doses and longer use. Based on this, periodic B12 checks for people on long-term metformin are a reasonable step that doctors commonly consider. Confidence is lower that metformin causes anemia directly, since the effect on hemoglobin appears small and varies. People with symptoms such as unusual tiredness, weakness, or numbness should talk to a doctor promptly, since these can have many causes. Anyone thinking about changing their medicine should consult their prescriber first.
People with type 2 diabetes who take metformin, especially those who have used it for several years or at higher doses, should find this information useful. Caregivers and healthcare providers who manage long-term diabetes care may also benefit. People who do not take metformin, or who have type 1 diabetes, will not be directly affected by these findings. Anyone with a known anemia or kidney problem should discuss their results with their doctor, who can weigh all the causes.
Vitamin B12 levels usually change slowly over months to years of treatment, so the risk builds over time rather than appearing right away. If a B12 shortage is found, correcting it can take several weeks to a few months, depending on how low levels are and what treatment is used. Hemoglobin changes, when they occur, may also take time to show up on routine blood tests. Regular checkups are the best way to catch these changes early.
Frequently Asked Questions
Does metformin cause low vitamin B12?
Research shows that metformin can lower vitamin B12 levels, and the risk appears to grow with higher doses and longer use. A 2026 review published in Current Medical Research and Opinion reported this pattern. Regular blood tests can help detect low B12 early, so your doctor can recommend the right next step for you.
Can metformin cause anemia in people with type 2 diabetes?
Metformin’s effect on anemia appears modest and varies from person to person. Anemia in diabetes often has several causes, including kidney disease and iron deficiency. A 2026 review suggests that low vitamin B12 is a plausible contributor, but doctors need to evaluate each case to find the cause.
How often should people on long-term metformin get B12 tested?
The 2026 review emphasizes regular clinical monitoring for people on long-term metformin, especially at higher doses. The exact testing schedule is not set in the review, so it is best to ask your doctor. They can recommend a schedule based on your dose, treatment length, and overall health.
Should I stop taking metformin if I am worried about anemia?
Do not stop metformin on your own. The review notes that metformin’s blood sugar benefits are well established, and the goal is to reduce preventable side effects while keeping those benefits. Talk to your doctor about blood tests and symptoms so any changes to your treatment are made safely.
Want to Apply This Research?
- Log the date you started metformin, your current daily dose, and the date of each vitamin B12 and hemoglobin blood test. Set a reminder to review these results with your doctor at the interval they recommend, and note any symptoms such as fatigue, shortness of breath, or tingling in your hands or feet on a weekly score from 1 to 5.
- Ask your doctor at your next visit whether your B12 level should be checked, and record the answer in the app. If your doctor recommends B12 foods or supplements, log them daily, such as eggs, dairy, fish, meat, or fortified cereals. Keep taking your metformin as prescribed unless your doctor tells you otherwise.
- Over the long term, track your blood test results in one place so you can see trends across years rather than single readings. Review the chart with your healthcare team at each routine checkup, and flag any drop in B12 or hemoglobin for follow-up. Update your symptom log whenever you notice changes, and bring the full record to appointments to support better decisions.
This article summarizes a narrative review of earlier research and is for general education only. It is not medical advice and does not replace guidance from your doctor or pharmacist. Do not start, stop, or change metformin or any other medicine, or any vitamin or supplement, without talking to your healthcare provider. If you have symptoms such as persistent tiredness, shortness of breath, or numbness or tingling, seek medical care promptly.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.